Gapping down
In reaction to disappointing earnings/guidance: JBL -17.6% (to divest aftermarket services for $725 million; downgraded to Sell from Neutral at Citigroup, downgraded at Needham), PAY -4%, GIS -2%, FDX -1.7%, ALB -0.4%, CFX -0.1%.
Other news: ONTX -17% (announces discontinuation of the Phase 3 ONTRAC study of intravenous rigosertib plus gemcitabine in front-line metastatic pancreatic cancer), TWGP -11.5% (announces sale of its 10.7% equity stake in Canopius Group ), OPXA -9.6% (prices 4.12 mln shares of common stock at $1.70 ), GOGO -5.6% (announces Ripplewood distribution and director resignations), WPCS -4.2% (announces acquisition of BTX Trader LLC, an early stage tech company engaged in developing a proprietary trading platform for bitcoins ), QCOR -3.9% (attributed to RTRX news), MWE -2.9% (has agreed to sell approximately 4,750,000 common units pursuant to a terms agreement under its equity distribution agreement with Citigroup), LNKD -1.8% (still checking), AAPL -1.3% (JBL related implications), GSK -1.1% (still checking), MU -1% (still checking), UPS -0.9% (following FDX results), SDRL -0.7% (still checking), OCRX -0.6% (Ocera Therapeutics and the Roche Group enter into technology transfer and license agreement), K -0.6% (following GIS results), TWO -0.4% (announces Q4 dividend of $0.26/share, down from prior $0.28/share), ETFC -0.3% (reports DARTs for November were 163,411, a 2% increase from October ).
Analyst comments: LSI -0.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley), KGC -0.4% (ticking lower; downgraded to Neutral from Overweight at JP Morgan)
Other news: ONTX -17% (announces discontinuation of the Phase 3 ONTRAC study of intravenous rigosertib plus gemcitabine in front-line metastatic pancreatic cancer), TWGP -11.5% (announces sale of its 10.7% equity stake in Canopius Group ), OPXA -9.6% (prices 4.12 mln shares of common stock at $1.70 ), GOGO -5.6% (announces Ripplewood distribution and director resignations), WPCS -4.2% (announces acquisition of BTX Trader LLC, an early stage tech company engaged in developing a proprietary trading platform for bitcoins ), QCOR -3.9% (attributed to RTRX news), MWE -2.9% (has agreed to sell approximately 4,750,000 common units pursuant to a terms agreement under its equity distribution agreement with Citigroup), LNKD -1.8% (still checking), AAPL -1.3% (JBL related implications), GSK -1.1% (still checking), MU -1% (still checking), UPS -0.9% (following FDX results), SDRL -0.7% (still checking), OCRX -0.6% (Ocera Therapeutics and the Roche Group enter into technology transfer and license agreement), K -0.6% (following GIS results), TWO -0.4% (announces Q4 dividend of $0.26/share, down from prior $0.28/share), ETFC -0.3% (reports DARTs for November were 163,411, a 2% increase from October ).
Analyst comments: LSI -0.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley), KGC -0.4% (ticking lower; downgraded to Neutral from Overweight at JP Morgan)